Nonagen Bioscience Corporation is a Los Angeles-based company dedicated to discovering and developing groundbreaking diagnostics for human diseases. Their focus lies in translating research discoveries into top-notch diagnostics that revolutionize disease management, providing doctors with advanced tools for disease detection, therapy selection, and disease monitoring.
With their pioneering product, Oncuria, Nonagen Bioscience aims to bring about a paradigm shift in the field of bladder cancer diagnostics. Oncuria is a unique multiplex protein immunoassay designed to detect bladder cancer, aid in its diagnosis, monitor individuals with early-stage bladder cancer for recurrence, and help identify those more likely to experience rapid failure with bacillus Calmette-Guérin (BCG) therapy, a primary treatment for bladder cancer.
Generated from the website